Report
Vishnu Lekraj
EUR 850.00 For Business Accounts Only

Morningstar | Department of Justice Approves Cigna-Express Deal; Merger Will Create a Powerful New Entity

Despite significant efforts by some pharmacy market participants and investors to scuttle the deal, the U.S. Department of Justice recently approved Cigna's merger with Express Scripts with very little pushback. This development falls in line with our expectations, as we have factored in a 100% chance of DOJ approval for the deal into our analysis for both firms. Thus, we are maintaining our $160 and $92 fair value estimates for Cigna and Express, respectively. Additionally, we are maintaining our no-moat and wide moat ratings for both the managed-care organization and pharmacy benefit manager, respectively. However, we plan to update our fair value and moat rating for Cigna after we fully incorporate our outlook for the combined entity. We expect the deal to officially close by the end of the year, with a full integration in 2019.

From our perspective, the new firm will be one of the strongest in the U.S. healthcare market, as the combination of Cigna’s sizable MCO and Express’ wide-moat PBM will form a powerful business. Operationally, the new entity will be a formidable force that will be able to wield significant pricing power and leverage top-tier scale advantages. We believe Cigna now has an opportunity to build a more powerful business by integrating Express’ wide-moat PBM operations with its solid MCO business. From our perspective, the new combined firm will possess a strong foundation that will expand the services, increase cross-sales, and ultimately enhance the competitive positioning for both firms. The more holistic insurance options the new healthcare-services company will be able to offer its clients will give it more flexibility when selling to prospects and we anticipate will help in winning new business. Additionally, the new conglomerate will also be able to leverage both businesses into better input pricing for pharmaceuticals and medical services--allowing it solid plan pricing and a lower overall cost structure per member.
Underlying
Express Scripts Holding Company

Express Scripts Holding is a pharmacy benefit management (PBM) company. The company has two reportable segments: PBM, which consists of clinical solutions, Express Scripts SafeGuardRx

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Vishnu Lekraj

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch